Загальні відомості про множинні ендокринні неоплазії (МЕН)

(Сімейний ендокринний аденоматоз; множинний ендокринний аденоматоз)

ЗаLawrence S. Kirschner, MD, PhD, The Ohio State University;
Pamela Brock, MS, CGC, The Ohio State University
Переглянуто/перевірено черв. 2023

    The multiple endocrine neoplasia (MEN) syndromes comprise 4 genetically distinct familial diseases involving adenomatous hyperplasia and malignant tumors in several endocrine glands.

    • MEN 1 involves primarily hyperplasia or sometimes adenomas of the parathyroid glands (with resultant hyperparathyroidism) and tumors of the pancreatic islet cells and/or pituitary gland.

    • MEN 2A involves primarily medullary thyroid carcinoma, pheochromocytoma, hyperplasia or sometimes adenomas of the parathyroid glands (with resultant hyperparathyroidism), and occasionally cutaneous lichen amyloidosis.

    • MEN 2B involves primarily medullary thyroid carcinoma, pheochromocytoma, multiple mucosal and intestinal neuromas, and marfanoid habitus.

    • MEN 4 involves primarily adenomas and sometimes hyperplasia of the parathyroid glands (with resultant hyperparathyroidism) and tumors of the pancreatic islet cells and/or pituitary gland.

    Clinical features depend on the glandular elements involved. The phenotype of MEN 4 is similar to that of MEN 1 but lacks the cutaneous abnormalities seen in the latter disorder.

    Таблиця
    Таблиця

    Each syndrome is inherited as an autosomal dominant trait with a high degree of penetrance, variable expressivity, and production of seemingly unrelated effects by a single mutant gene. The specific mutation is not always known.

    Symptoms and signs develop at any age. Proper management includes early identification of affected individuals within a kindred and surgical removal of the tumors when possible. Although these syndromes are genetically and clinically distinct, significant overlap exists (see table Conditions Associated With MEN Syndromes).